Evaluation of the Third 90 of the 90-90-90 Cascade for the Period 2019-2020 in the Central African Republic
Gilles Ngaya, B. Yambiyo, Alain Farra, Pulchérie Pélembi, A. Béré, D. Golongba, S. Kamadom, A. Berlioz-Arthaud
{"title":"Evaluation of the Third 90 of the 90-90-90 Cascade for the Period 2019-2020 in the Central African Republic","authors":"Gilles Ngaya, B. Yambiyo, Alain Farra, Pulchérie Pélembi, A. Béré, D. Golongba, S. Kamadom, A. Berlioz-Arthaud","doi":"10.4236/wja.2021.114014","DOIUrl":null,"url":null,"abstract":"Introduction In Central-African Republic, according to UNAIDS in 2019, out of approximately 100,000 people living with HIV, 70% (72,000) knew their HIV status and 47,000 (46%) were on ARV therapy; however, there is a paucity of data on viral load suppression in people on ARV therapy. The objective of this study was to assess the third 90 of the UNAIDS strategy for the years 2019 and 2020 in the CAR. Methods We analyzed the available viral load data extracted from the data base of the medical analysis laboratory (SYSLAM) of the Institut Pasteur of Bangui for the years 2019 and 2020. The viral loads were determined based on plasma collected in an EDTA tube with Cepheid’s GeneXpert 16-module controllers. Viral load data were extracted from SYSLAM, converted to Excel format, and analyzed with STATA version 14 software. The significance threshold for the statistical tests was set at 5%. Results This study included 22,895 patients, of who 72% were female. The average age was 40.82 years, and the majority of the patients (80%) came from the city of Bangui. Regarding the virological parameters associated with this study, 66% of the patients had significant viral load suppression according to the WHO recommendations and 34% were in virological failure. Patients over 50 years of age (71.85%) and age group 40 49 years (69.25%) recorded significant levels of viral load suppression. On the other hand, 63.45% of patients under 18 years of age had virological failure. All of these results were statistically significant (p < 0.005). Conclusion There should be a concerted effort, to make viral load accessible and available to all patients receiving ARV treatment in the CAR and the management of HIV/AIDS infection of children and adolescents should be given special attention. How to cite this paper: Ngaya, G.S.L., Yambiyo, B.M., Farra, A., Pelembi, P., Bere, A., Golongba, D., Kamadom, S. and BerliozArthaud, A. (2021) Evaluation of the Third 90 of the 90-90-90 Cascade for the Period 2019-2020 in the Central African Republic. World Journal of AIDS, 11, 189-198. https://doi.org/10.4236/wja.2021.114014 Received: October 12, 2021 Accepted: December 27, 2021 Published: December 30, 2021 Copyright © 2021 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access G. S. L. Ngaya et al. DOI: 10.4236/wja.2021.114014 190 World Journal of AIDS","PeriodicalId":58633,"journal":{"name":"艾滋病(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"艾滋病(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/wja.2021.114014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction In Central-African Republic, according to UNAIDS in 2019, out of approximately 100,000 people living with HIV, 70% (72,000) knew their HIV status and 47,000 (46%) were on ARV therapy; however, there is a paucity of data on viral load suppression in people on ARV therapy. The objective of this study was to assess the third 90 of the UNAIDS strategy for the years 2019 and 2020 in the CAR. Methods We analyzed the available viral load data extracted from the data base of the medical analysis laboratory (SYSLAM) of the Institut Pasteur of Bangui for the years 2019 and 2020. The viral loads were determined based on plasma collected in an EDTA tube with Cepheid’s GeneXpert 16-module controllers. Viral load data were extracted from SYSLAM, converted to Excel format, and analyzed with STATA version 14 software. The significance threshold for the statistical tests was set at 5%. Results This study included 22,895 patients, of who 72% were female. The average age was 40.82 years, and the majority of the patients (80%) came from the city of Bangui. Regarding the virological parameters associated with this study, 66% of the patients had significant viral load suppression according to the WHO recommendations and 34% were in virological failure. Patients over 50 years of age (71.85%) and age group 40 49 years (69.25%) recorded significant levels of viral load suppression. On the other hand, 63.45% of patients under 18 years of age had virological failure. All of these results were statistically significant (p < 0.005). Conclusion There should be a concerted effort, to make viral load accessible and available to all patients receiving ARV treatment in the CAR and the management of HIV/AIDS infection of children and adolescents should be given special attention. How to cite this paper: Ngaya, G.S.L., Yambiyo, B.M., Farra, A., Pelembi, P., Bere, A., Golongba, D., Kamadom, S. and BerliozArthaud, A. (2021) Evaluation of the Third 90 of the 90-90-90 Cascade for the Period 2019-2020 in the Central African Republic. World Journal of AIDS, 11, 189-198. https://doi.org/10.4236/wja.2021.114014 Received: October 12, 2021 Accepted: December 27, 2021 Published: December 30, 2021 Copyright © 2021 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access G. S. L. Ngaya et al. DOI: 10.4236/wja.2021.114014 190 World Journal of AIDS
中非共和国2019-2020年期间90-90-90级联计划第三阶段90的评估
在中非共和国,根据联合国艾滋病规划署2019年的数据,在大约10万名艾滋病毒感染者中,70%(7.2万人)知道自己感染了艾滋病毒,4.7万人(46%)正在接受抗逆转录病毒治疗;然而,在接受抗逆转录病毒治疗的人群中,缺乏病毒载量抑制的数据。本研究的目的是评估联合国艾滋病规划署2019年和2020年中非共和国战略的第三个目标。方法对班吉巴斯德研究所医学分析实验室(SYSLAM)数据库中提取的2019年和2020年病毒载量数据进行分析。利用造父变星的GeneXpert 16模块控制器采集EDTA管中的血浆,确定病毒载量。从SYSLAM中提取病毒载量数据,转换为Excel格式,使用STATA version 14软件进行分析。统计学检验的显著性阈值设为5%。结果共纳入22,895例患者,其中72%为女性。平均年龄40.82岁,大部分患者(80%)来自班吉市。关于与本研究相关的病毒学参数,根据世卫组织的建议,66%的患者有明显的病毒载量抑制,34%的患者病毒学失败。50岁以上患者(71.85%)和40 - 49岁年龄组(69.25%)记录了显著水平的病毒载量抑制。另一方面,18岁以下患者的病毒学失败率为63.45%。这些结果均有统计学意义(p < 0.005)。结论应共同努力,使中非共和国所有接受抗逆转录病毒治疗的患者都能获得病毒载量,并应特别重视儿童和青少年艾滋病毒/艾滋病感染的管理。如何引用本文:Ngaya, g.s.l., Yambiyo, b.m., Farra, A., Pelembi, P., Bere, A., Golongba, D., Kamadom, S.和BerliozArthaud, A.(2021)中非共和国2019-2020年期间90-90-90级反应的第三个90的评估。世界艾滋病杂志,11,189-198。https://doi.org/10.4236/wja.2021.114014收稿日期:2021年10月12日收稿日期:2021年12月27日出版日期:2021年12月30日版权所有©作者与科研出版公司。本作品采用知识共享署名国际许可协议(CC BY 4.0)。http://creativecommons.org/licenses/by/4.0/ Open Access g.s.l. Ngaya等。DOI: 10.4236/wja.2021.114014 190世界艾滋病杂志
本文章由计算机程序翻译,如有差异,请以英文原文为准。